p-Measles virus Antibody (9H4): sc-101356

p-Measles virus Antibody (9H4) is a mouse monoclonal IgG1 antibody that detects the phosphorylated Measles virus protein of non-species reactive by western blotting (WB), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). p-Measles virus (9H4) antibody is available in a non-conjugated form, providing flexibility for various experimental needs. Measles virus (MV), also known as rubeola, is a highly contagious acute viral illness caused by a paramyxovirus of the genus Morbillivirus, characterized by its enveloped and nonsegmented negative-stranded RNA structure. MV primarily infects epithelial cells and can replicate in various tissues, including the urinary tract, conjunctivae, blood vessels, lymphatic system, and central nervous system, which underscores the importance of understanding cellular interactions. Notably, MV contains two critical envelope glycoproteins, the haemagglutinin (H) and fusion proteins, which facilitate membrane fusion and attachment to host cells, playing a vital role in viral spread and disease progression. Additionally, protein V, which represses genome replication, highlights the complexity of MV′s interaction with the host′s cellular machinery, as this protein may act as an RNA-binding modulatory factor, influencing viral pathogenesis and immune evasion. Given the severe complications associated with measles, including pneumonia, diarrhea, and encephalitis, accurate detection and study of phosphorylated MV using anti-Measles virus antibody (9H4) is crucial for advancing research and developing effective therapeutic strategies.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

p-Measles virus Antibody (9H4) References:

1. Role of V protein RNA binding in inhibition of measles virus minigenome replication.  |  Parks, CL., et al. 2006. Virology. 348: 96-106. PMID: 16442140
2. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.  |  Iankov, ID., et al. 2006. J Virol. 80: 8530-40. PMID: 16912303
3. Measles virus: cellular receptors, tropism and pathogenesis.  |  Yanagi, Y., et al. 2006. J Gen Virol. 87: 2767-2779. PMID: 16963735
4. Induction of basic fibroblast growth factor in Alzheimer's disease pathology.  |  Gómez-Pinilla, F., et al. 1990. Neuroreport. 1: 211-4. PMID: 1717039
5. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.  |  Vijayaraghavan, M., et al. 2007. Health Policy. 83: 27-36. PMID: 17174435
6. Measles--United States, 2005.  |  ,. 2006. MMWR Morb Mortal Wkly Rep. 55: 1348-51. PMID: 17183226
7. Measles still has a devastating impact in unvaccinated populations.  |  Moss, WJ. 2007. PLoS Med. 4: e24. PMID: 17199409
8. The Measles Initiative to control measles in Kenya.  |  Bradsher, CA., et al. 2007. Public Health Nurs. 24: 26-33. PMID: 17214650